Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease [Phase 2]
Phase 2 clinical trial results on optimizing and standardizing 129Xe gas exchange MRI to visualize regional therapy response in interstitial…
-
EMA approval · 2026-06-25EMA Authorised: Nintedanib Accord (nintedanib) — Accord Healthcare S.L.U.
EU authorization of Nintedanib Accord for idiopathic pulmonary fibrosis and related interstitial lung diseases, expanding treatment options …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Aerobic Exercise in Patients With Pulmonary Hypertension [Phase 2]
Phase 2 clinical trial update on aerobic exercise in patients with pulmonary hypertension (including interstitial lung disease) has complete…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial is evaluating whether inhaled L-menthol reduces breathlessness in people with interstitial lung disease; enrollment…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2, Phase 3]
Extension study update for Treprostinil Palmitil Inhalation Powder (TPIP) in pulmonary hypertension associated with interstitial lung diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of inhaled treprostinil for progressive pulmonary fibrosis, with recruitment …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases [Phase 3]
A Phase 3 study by Boehringer Ingelheim is testing nerandomilast for interstitial lung disease related to systemic autoimmune rheumatic dise…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD [Phase 2]
Phase 2 clinical trial evaluating mosliciguat in combination with inhaled treprostinil for pulmonary hypertension associated with interstiti…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Feasibility of Semaglutide in Advanced Lung Disease [Phase 1, Phase 2]
Feasibility study of the GLP-1 agonist semaglutide for patients with obesity and advanced lung diseases, spanning Phase 1 and Phase 2, curre…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression [Phase 3]
A Phase 3 trial named FIBRONEER-ACT is evaluating nerandomilast for fibrosing interstitial lung disease at risk for progression. The study i…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases [NA]
A clinical trial update indicating recruitment is ongoing for a study focused on early recognition of progressive lung fibrosis in systemic …
-
CLINICAL_TRIALS other · 2026-04-20Clinical Trial Update: Collagen-targeted PET Imaging for Early Interstitial Lung Disease [Phase 2]
Phase 2 clinical trial update from Massachusetts General Hospital evaluating collagen-targeted PET imaging for early interstitial lung disea…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy [NA]
This update describes initial experience with the disposable Celsio Cryocatheter System for diagnostic and interventional bronchoscopy in lu…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
This clinical trial registry entry describes the DeciPHer-ILD real-world patient registry focused on Group 3 pulmonary hypertension associat…
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: RaDiCo PID Cohort (RaDiCo-ILD Cohort in English)
RaDiCo PID Cohort (RaDiCo-ILD) trial in pediatric and adult patients with idiopathic interstitial pneumonia/ILD has been terminated.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis [Phase 3]
A Phase 3 clinical trial evaluating nerandomilast to slow progression in people with familial pulmonary fibrosis and related interstitial lu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters
A clinical trial update on building a clinico-imaging diagnostic model for Dermatomyositis with interstitial lung disease using PET/CT featu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 3]
This clinical trial update indicates that Insmed's Treprostinil Palmitil Inhalation Powder (TPIP) is being studied in a Phase 3 trial for ef…
-
CLINICAL_TRIALS withdrawal · 2026-04-13Clinical Trial Update: Lung Cancer Screening CT for Firefighters [NA]
A clinical trial evaluating CT-based lung cancer screening for firefighters has been withdrawn, according to the sponsor University of Calif…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial [NA]
The OPTIMIZE-ILD-1 trial aiming to optimize the diagnostic journey for interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study [Phase 2]
Phase 2 trial update for emapalumab in rapidly progressive interstitial lung disease associated with dermatomyositis; the study is not yet r…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease [Phase 3]
Phase 3 clinical trial evaluating the combination of nintedanib and tocilizumab for systemic sclerosis with interstitial lung disease is cur…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]
A Phase 3 trial evaluating inhaled treprostinil for idiopathic pulmonary fibrosis and interstitial lung disease has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating inhaled AP01 for progressive pulmonary fibrosis is currently recruiting, with no results yet reported.